Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial–mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells

References

• NijveldtRJvan NoodEvan HoornDEBoelensPGvan NorrenKvan LeeuwenPAFlavonoids: a review of probable mechanisms of action and potential applicationsAm J Clin Nutr200174441842511566638
   PubMed Web of Science ®Google Scholar
• RossJAKasumCMDietary flavonoids: bioavailability, metabolic effects, and safetyAnnu Rev Nutr200222193412055336
   PubMed Web of Science ®Google Scholar
• MiddletonEJrKandaswamiCTheoharidesTCThe effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancerPharmacol Rev200052467375111121513
   PubMed Web of Science ®Google Scholar
• WangTZhangJCChenYHuangFYangMSXiaoPGComparison of antioxidative and antitumor activities of six flavonoids from Epimedium koreanumZhongguo Zhong Yao Za Zhi200732871571817608228
   PubMedGoogle Scholar
• KandaswamiCLeeLTLeePPThe antitumor activities of flavonoidsIn Vivo200519589590916097445
   PubMed Web of Science ®Google Scholar
• JiaZNallasamyPLiuDLuteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IκBα/NF-κB signaling pathwayJ Nutr Biochem201526329330225577468
   PubMed Web of Science ®Google Scholar
• TheoharidesTCContiPEconomuMBrain inflammation, neuropsychiatric disorders, and immunoendocrine effects of luteolinJ Clin Psychopharmacol201434218718924525647
   PubMed Web of Science ®Google Scholar
• YangMYWangCJChenNFHoWHLuFJTsengTHLuteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3Chem Biol Interact2014213606824525192
   PubMed Web of Science ®Google Scholar
• ShiRXOngCNShenHMLuteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cellsOncogene200423467712772115334063
   PubMed Web of Science ®Google Scholar
• HongZCaoXLiNLuteolin is effective in the non-small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistanceBr J Pharmacol2014171112842285324471765
   PubMed Web of Science ®Google Scholar
• CaiXYeTLiuCLuteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cellsToxicol In Vitro20112571385139121601631
   PubMed Web of Science ®Google Scholar
• ChoiEMLeeYSLuteolin suppresses IL-1beta-induced cytokines and MMPs production via p38 MAPK, JNK, NF-kappaB and AP-1 activation in human synovial sarcoma cell line, SW982Food Chem Toxicol201048102607261120600535
   PubMed Web of Science ®Google Scholar
• BagliEStefaniotouMMorbidelliLLuteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activityCancer Res200464217936794615520200
   PubMed Web of Science ®Google Scholar
• YuHShenYHongJXiaQZhouFLiuXThe contribution of TGF-beta in Epithelial-Mesenchymal Transition (EMT): down-regulation of E-cadherin via snailNeoplasma201562111525563362
   PubMed Web of Science ®Google Scholar
• NakajimaSDoiRToyodaEN-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinomaClin Cancer Res20041012 Pt 14125413315217949
   PubMed Web of Science ®Google Scholar
• ShaulYDFreinkmanECombWCDihydropyrimidine accumulation is required for the epithelial-mesenchymal transitionCell201415851094110925171410
   PubMed Web of Science ®Google Scholar
• AndreolasCKalogeropoulouMVoulgariAPintzasAFra-1 regulates vimentin during Ha-RAS-induced epithelial mesenchymal transition in human colon carcinoma cellsInt J Cancer200812281745175618098284
   PubMed Web of Science ®Google Scholar
• NietoMACanoAThe epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticitySemin Cancer Biol2012225–636136822613485
   PubMed Web of Science ®Google Scholar
• QianLWMizumotoKUrashimaTRadiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023Clin Cancer Res2002841223122711948136
   PubMed Web of Science ®Google Scholar
• FukudaAWangSCMorrisJPStat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progressionCancer Cell201119444145521481787
   PubMed Web of Science ®Google Scholar
• ItoHDuxburyMBenoitEProstaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2Cancer Res200464207439744615492268
   PubMed Web of Science ®Google Scholar
• NagakawaYAokiTKasuyaKTsuchidaAKoyanagiYHistologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancerPancreas200224216917811854622
   PubMed Web of Science ®Google Scholar
• DehaiCBoPQiangTEnhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6Immunol Lett2014160111024698728
   PubMed Web of Science ®Google Scholar
• SullivanNJSasserAKAxelAEInterleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cellsOncogene200928332940294719581928
   PubMed Web of Science ®Google Scholar
• HuangCYangGJiangTZhuGLiHQiuZThe effects and mechanisms of blockage of STAT3 signaling pathway on IL-6 inducing EMT in human pancreatic cancer cells in vitroNeoplasma201158539640521744993
   PubMed Web of Science ®Google Scholar
• ChenYDengJFujimotoJGprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factorCancer Res201070218917892620959490
   PubMed Web of Science ®Google Scholar
• CuiWLiuYWeinsteinJSCraftJKaechSMAn interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cellsImmunity201135579280522118527
   PubMed Web of Science ®Google Scholar
• ZhangYDuXLWangCJReciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cellsGastroenterology20121423521530e52322108192
   PubMed Web of Science ®Google Scholar
• HeZHeXChenZActivation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in miceOncol Rep20143251873188025174408
   PubMed Web of Science ®Google Scholar
• BaumgartSChenNMSivekeJTInflammation-induced NFATc1-STAT3 transcription complex promotes pancreatic cancer initiation by KrasG12DCancer Discov20144668870124694735
   PubMed Web of Science ®Google Scholar
• CorcoranRBContinoGDeshpandeVSTAT3 plays a critical role in KRAS-induced pancreatic tumorigenesisCancer Res201171145020502921586612
   PubMed Web of Science ®Google Scholar
• BlackfordASerranoOKWolfgangCLSMAD4 gene mutations are associated with poor prognosis in pancreatic cancerClin Cancer Res200915144674467919584151
   PubMed Web of Science ®Google Scholar
• ChenHTuHMengZQChenZWangPLiuLMK-ras mutational status predicts poor prognosis in unresectable pancreatic cancerEur J Surg Oncol201036765766220542658
   PubMed Web of Science ®Google Scholar
• BernhardJDietrichDGlimeliusBEstimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapyBr J Cancer201010391318132420877359
   PubMed Web of Science ®Google Scholar
• JohnsonJLDiaVPWalligMGonzalez de MejiaELuteolin and gemcitabine protect against pancreatic cancer in an orthotopic mouse modelPancreas201544114415125237909
   PubMed Web of Science ®Google Scholar
• CaiXLuWYeTThe molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cellsOncol Rep20122841353136122825765
   PubMed Web of Science ®Google Scholar
• LeeLTHuangYTHwangJJBlockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cellsAnticancer Res20022231615162712168845
   PubMed Web of Science ®Google Scholar
• ZhangDMaXWuBCuiPLiuHLuZEffect of MSX2 interference on epithelial-mesenchymal transitions of pancreatic cancer cell line PANC-1Nan Fang Yi Ke Da Xue Xue Bao201535217918425736109
   PubMedGoogle Scholar
• StahleMVeitCBachfischerUMechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERKJ Cell Sci2003116Pt 183835384612902401
   PubMed Web of Science ®Google Scholar
• AsuthkarSNallaAKGondiCSGadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMTNeuro Oncol201113101059107321813510
   PubMed Web of Science ®Google Scholar
• RadiskyDCLevyDDLittlepageLERac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instabilityNature2005436704712312716001073
   PubMed Web of Science ®Google Scholar
• LuWXiaYHQuJJp21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretionNeoplasma201360549350323790167
   PubMed Web of Science ®Google Scholar
• XuCHuDMZhuQeEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activationClin Exp Metastasis201330793394423739844
   PubMed Web of Science ®Google Scholar
• BalanisNWendtMKSchiemannBJWangZSchiemannWPCarlinCREpithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathwayJ Biol Chem201328825179541796723653350
   PubMed Web of Science ®Google Scholar
• GuoLChenCShiMStat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transitionOncogene201332455272528223318420
   PubMed Web of Science ®Google Scholar
• GujralTSChanMPeshkinLSorgerPKKirschnerMWMacBeathGA noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasisCell2014159484485625417160
   PubMed Web of Science ®Google Scholar
• LuZWangJZhengTFTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by deactivating STAT3 signalingBMC Cancer20141478325344679
   PubMed Web of Science ®Google Scholar
• LesinaMKurkowskiMULudesKStat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancerCancer Cell201119445646921481788
   PubMed Web of Science ®Google Scholar
• DicitoreACaragliaMGaudenziGType I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferationBiochim Biophys Acta201418451425224295567
   PubMed Web of Science ®Google Scholar
• VitaleGZappavignaSMarraMThe PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cellsBiotechnol Adv201230116918421871555
   PubMed Web of Science ®Google Scholar